MORE Savings Act
USA118th CongressHR-1620| House
| Updated: 3/24/2023
Madeleine Dean
Democratic Representative
Pennsylvania
Cosponsors (1)
Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Maximizing Opioid Recovery Emergency Savings Act or the MORE Savings Act This bill modifies coverage of opioid treatments and recovery support services under Medicare, Medicaid, and private health insurance. Specifically, the bill requires the Center for Medicare and Medicaid Innovation to test a model in which specified opioid treatments and recovery support services are provided under Medicare without cost-sharing (e.g., coinsurance, copayments, and deductibles). The bill also allows state Medicaid programs to cover recovery support services as part of medication-assisted treatment (MAT) and increases the applicable Federal Medical Assistance Percentage for MAT. Additionally, beginning in 2025, private health insurers must cover specified opioid treatments and MAT-associated recovery support services without cost-sharing.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Health
Drug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesHealth care costs and insuranceHealth care coverage and accessMedicaidMental healthPhysical fitness and lifestylePrescription drugsRural conditions and development
MORE Savings Act
USA118th CongressHR-1620| House
| Updated: 3/24/2023
Maximizing Opioid Recovery Emergency Savings Act or the MORE Savings Act This bill modifies coverage of opioid treatments and recovery support services under Medicare, Medicaid, and private health insurance. Specifically, the bill requires the Center for Medicare and Medicaid Innovation to test a model in which specified opioid treatments and recovery support services are provided under Medicare without cost-sharing (e.g., coinsurance, copayments, and deductibles). The bill also allows state Medicaid programs to cover recovery support services as part of medication-assisted treatment (MAT) and increases the applicable Federal Medical Assistance Percentage for MAT. Additionally, beginning in 2025, private health insurers must cover specified opioid treatments and MAT-associated recovery support services without cost-sharing.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Madeleine Dean
Democratic Representative
Pennsylvania
Cosponsors (1)
Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee
Health
Related Bills
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Drug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesHealth care costs and insuranceHealth care coverage and accessMedicaidMental healthPhysical fitness and lifestylePrescription drugsRural conditions and development